Apollo Endosurgery (APEN) – StreetInsider.com Reports
-
Cowen Downgrades Apollo Endosurgery (APEN) to Market Perform
-
Stifel Downgrades Apollo Endosurgery (APEN) to Hold
-
Lake Street Capital Markets Downgrades Apollo Endosurgery (APEN) to Hold Pending Takeover
-
Craig-Hallum Sees Potential Higher Offer for Apollo Endosurgery (APEN)
-
Boston Scientific (BSX) to Acquire Apollo Endosurgery (APEN) for $10 Per Share, $615 million Deal
-
Stifel Reiterates Buy Rating, $10 Price Target on Apollo Endosurgery (APEN) Post Earnings
-
Apollo Endosurgery (APEN) Reports Publication of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
-
Apollo Endosurgery (APEN) Reiterates at Buy with $10 Price Target by Stifel, Approved ESG and REVISE are "Next Critical Growth Drivers"
-
Apollo Endosurgery (APEN) Announces FDA Grants De Novo Marketing Authorization to for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity
-
Stifel Reiterates Buy Rating, $10 Price Target on Apollo Endosurgery (APEN)
-
Stifel Reiterates Buy Rating, $10 Price Target on Apollo Endosurgery (APEN)
-
Apollo Endosurgery (APEN) PT Lowered to $8 at Stephens
-
Apollo Endosurgery (APEN) PT Lowered to $10 at Stifel on Market Multiple Compression, but Multiple Growth Drivers Should Drive Sustained Expansion
-
Apollo Endosurgery (APEN) Reports Prelim 2021 Results
-
UPDATE: Cowen Starts Apollo Endosurgery (APEN) at Outperform
-
UPDATE: Stifel Starts Apollo Endosurgery (APEN) at Buy
-
Apollo Endosurgery (APEN) PT Lowered to $13 at Stephens
-
Apollo Endosurgery (APEN) gets Australian Therapeutic Goods Administration approval for its X-Tack Endoscopic Helical Tacking System
-
Pre-Open Stock Movers 10/13: (WTRH) (KOSS) (RVNC) Higher; (RGLS) (ARDX) (STIM) Lower (more...)
-
Apollo Endosurgery (APEN) Prices 8.4M Share Common Stock Offering at $7.75/sh
-
After-Hours Stock Movers 10/12: (JSPR) (VST) (QCOM) Higher; (RGLS) (STIM) (RZLT) Lower (more...)
-
Apollo Endosurgery (APEN) Commences Common Stock Offering
-
UPDATE: Stephens Starts Apollo Endosurgery (APEN) at Overweight
-
Apollo Endosurgery (APEN) Appoints Jeffrey G. Black as CFO
-
Lake Street Capital Markets Starts Apollo Endosurgery (APEN) at Buy
-
Apollo Endosurgery (APEN) PT Raised to $14 at Craig-Hallum
-
Apollo Endosurgery (APEN) PT Raised to $8 at Piper Sandler
-
Apollo Endosurgery (APEN) Catalyst Opens the Door to Reimbursement for Orbera - Craig-Hallum
-
Apollo Endosurgery (APEN) announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures
-
Pre-Open Stock Movers 03/01: (ALSN) (APEN) (VACQ) Higher; (ATNX) (CRMD) (OTRK) Lower (more...)
-
Apollo Endosurgery (APEN) Climbs 100% After Announcing FDA Breakthrough Device Designation for the Orbera Intragastric Balloon for Treatment of Patients with NASH
-
Apollo Endosurgery (APEN) Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASH
-
Apollo Endosurgery (APEN) PT Raised to $9 at Craig-Hallum
-
Apollo Endosurgery (APEN) Announces CEO Transition
-
Pre-Open Stock Movers 12/16: (SIOX) (TLRY) (PTGX) Higher; (VTVT) (PEN) (SHSP) Lower (more...)
-
After-Hours Stock Movers 12/15: (SIOX) (TLRY) (APHA) Higher; (SHSP) (PEN) (DISH) Lower (more...)
-
Apollo Endosurgery (APEN) Receives FDA Clearance for the X-Tack Endoscopic HeliX Tacking System
-
Pre-Open Stock Movers 11/30: (CAAS) (MRNA) (WORK) Higher; (NKLA) (YJ) (NVAX) Lower (more...)
-
Piper Sandler Upgrades Apollo Endosurgery (APEN) to Overweight; 'Risk-Reward Skews Favorably'
-
Silk Road Medical Inc. (SILK) Announces Rick Anderson to Board
-
Apollo Endosurgery (APEN) Completes 510k Submission for FDA Clearance for X-Tack(TM) Endoscopic HeliX Tacking System
-
UPDATE: Piper Sandler Downgrades Apollo Endosurgery (APEN) to Neutral
-
Apollo Endosurgery (APEN) Tops Q3 EPS by 2c
-
Apollo Endosurgery (APEN) Receives 510(k) Clearance for Polypropylene Suture-Anchor Assembly
-
Apollo Endosurgery (APEN) Misses Q2 EPS by 2c
-
Apollo Endosurgery (APEN) Reports Complete Patient Enrollment for Multi-Center ESG Randomized Interventional Trial
-
Apollo Endosurgery (APEN) Announces US Labeling Update on the ORBERA Intragastric Balloon System
-
Apollo Endosurgery (APEN) Tops Q1 EPS by 23c, Revenues In-Line
-
Apollo Endosurgery (APEN) Announces John Barr to Board
-
Apollo Endosurgery (APEN) Misses Q4 EPS by 47c, Revenues Beat
Back to APEN Stock Lookup